We’re proud to share that Arbele Bio has been recognized as one of the Top 50 Innovative Biotech Emerging Companies of the Greater Bay Area!The award was presented on October 15 in Shenzhen, following six months of expert evaluations and on-site reviews.On the same day, our Chief Business Officer, Zijun(Alex) Wang, delivered a presentation at the 9th Asia Cell & Gene Therapy Innovation Summit, where he introduced CDH17, a safe and highly specific cancer target with broad potential across gastrointestinal and other cancers.At Arbele, we are one of the leading biotech companies advancing 𝗖𝗗𝗛𝟭𝟳-𝗯𝗮𝘀𝗲𝗱 𝗶𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀, including T-cell engagers and antibody-drug conjugates (ADCs), driving forward precision treatment options for patients with high unmet medical needs.The 𝗧𝗼𝗽 𝟱𝟬 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗚𝗿𝗲𝗮𝘁𝗲𝗿 𝗕𝗮𝘆 𝗔𝗿𝗲𝗮 award is organized by the China Innovation Industry Research Institute and hosted by Guangdong Medical Valley, and is recognized as one of the most influential CGT (Cell & Gene Therapy) events in the Asia-Pacific region.✨ This recognition reinforces our commitment to source-driven innovation and our mission to transform cancer treatment through novel immunotherapies.

‍#Arbelehashtag #BiotechInnovation #CDH17 #Immunotherapy #CellandGeneTherapy #GreaterBayArea #CancerResearch